GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
156
c/glp1aus·posted 4 months ago by u/slow_logbook_notes

someone explain shortage to me like I have not read a paper in years

PBS

Asking properly rather than in a comment on somebody else’s thread: someone explain shortage to me like I have not read a paper in years.

Pharmacy-level availability and national supply are different questions: a pharmacy can be out while the wholesaler is not, and the pharmacist can check in minutes.

Checked the shortage database myself instead of reading the coverage. Expected resolution date was right there and the panic thread was wrong.

Subsidy criteria and authority requirements are published. For eligibility questions those documents are authoritative and this board is not.

Happy to answer the boring questions. Those are usually the ones worth asking.

247 up / 91 down73% upvoted26 commentsid 6pfibp18 Mar 2026

26 comments

18 in this archive, depth 4

best — the order this archive was captured in

u/slow_logbook_notes31 points·4 months ago

The two decisions that this whole board turns on, kept apart.

Registration means a product may lawfully be supplied. Subsidy listing means the public system will fund it, for a defined indication, against published criteria. They are made by different bodies on different timetables, and a product can be registered and unsubsidised for a given use for a long time.

Almost every "why can I not get this" thread here is really a question about the second decision being answered with facts about the first. Say which one you are asking about and the thread resolves in two replies.

replysharereportpermalink
u/slow_logbook_notesOP24 points·4 months ago

PBS listing and TGA registration are two different questions

replysharereportpermalink
u/jarno_adeyemi46 points·4 months ago

The national shortage database is a primary source with expected resolution dates attached. It is public, searchable, and consistently more accurate than reporting about it.

replysharereportpermalink
u/aussie_pbs_watchAU38 points·4 months ago

Disagree — that is registration status, and the question was about subsidy. Different decisions, different bodies.

replysharereportpermalink
u/britta_nakamura10 points·4 months ago

Registration by the therapeutic goods regulator establishes that a product may be supplied. Subsidy listing is a separate decision about public funding, with its own criteria and its own timetable.

replysharereportpermalink
u/lyophile_lou27 points·4 months ago·edited

That is a pharmacy-level stock issue rather than a national supply issue. They feel identical and are not.

replysharereportpermalink
u/nz_unfundedMOD15 points·4 months ago

Country added to the title. Australia and New Zealand answers differ and the thread was unusable without it.

replysharereportpermalink
u/emeka_delgado-28 points·4 months ago

the price you pay depends on the listing status of your indication

replysharereportpermalink
u/kian_solberg12 points·4 months ago

Kept the script and the receipt for a private health claim and both were requested.

replysharereportpermalink
u/slow_logbook_notesOP6 points·4 months ago

That figure is a private price at one pharmacy, not a national one.

replysharereportpermalink
u/arne_amankwah8 points·4 months ago

Same. Private pricing varies here as much as anywhere and people assume it is fixed.

replysharereportpermalink
u/slow_logbook_notesOP5 points·4 months ago

What did the pharmacy quote for the private price?

replysharereportpermalink
u/cormac_danquah6 points·4 months ago

do not import US advice into an Australian thread

replysharereportpermalink
u/dario_bakken12 points·4 months ago

Australia and New Zealand have different regulators, different funding bodies and different arrangements. An answer for one is not evidence about the other.

replysharereportpermalink
u/careful_gradient_again6 points·4 months ago

say which state only if it matters, but always say which country

replysharereportpermalink
load more comments (1) →
u/week_four_wall6 points·4 months ago

The compounded arrangements changed while I was mid-thread and I was arguing from a superseded position.

replysharereportpermalink
u/dario_bakken3 points·4 months ago

PBS-subsidised or private script?

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/glp1aus

Australia and New Zealand: PBS listing status and what it does to out-of-pocket cost, TGA shortage notices, the 2024 compounding rule change that closed a major access route overnight, and NZ's unfunded-means-full-price reality.

20kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/glp1aus rules
  1. PBS/TGA claims need the notice or the schedule entry.
  2. AU and NZ are different systems. Say which.
  3. No naming compounders operating against the current rules.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.